Age Intervention Eyelash Products Seized by the FDA

Jenny Albano

Contributor

0 CommentsPrint ArticleSubscribe

The FDA has had almost $2 million worth of Age Intervention Eyelash applicator tubes seized because the product has lead to decreased vision in some consumers. The manufacturer, Jan Marini Skin Research, had 12,682 tubes seized by U.S. Marshals.

The FDA considers Age Intervention Eyelash to be an unapproved and misbranded drug because Jan Marini Skin Research has promoted the product to increase eyelash growth. Before a new drug product may be legally marketed, it must be shown to be safe and effective, and approved by FDA.

The FDA stated that the product is an adulterated cosmetic and contains bimatroprost, which is a drug that increases pressure inside the eyes. Consumers that use this ingrediant in other drugs as well as in the seized product may increase their risk for optic nerve damage because the extra bimatropost decreases the effectiveness of the prescribed drug. If the optic nerve becomes damaged the patient may become blind or start to lose their vision.

The Age Intervention Eyelash can cause people to have swelling of the retina (macular edema) and inflammation of the eye (uveitis).

Jan Marini Skin Research has informed the FDA that the it has stopped manufacturing and distributing all Age Intervention Eyelash products containing bimatoprost in last year.

For more information on this subject, please refer to our section on Defective and Dangerous Products.